Krishnan Nandabalan - Net Worth and Insider Trading
Krishnan Nandabalan Net Worth
The estimated net worth of Krishnan Nandabalan is at least $16 Million dollars as of 2024-05-24. Krishnan Nandabalan is the Director, 10% Owner of BioXcel Therapeutics Inc and owns about 8,546,750 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $16 Million. Details can be seen in Krishnan Nandabalan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Krishnan Nandabalan has not made any transactions after 2023-04-06 and currently still holds the listed stock(s).
Transaction Summary of Krishnan Nandabalan
Krishnan Nandabalan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Krishnan Nandabalan owns 1 companies in total, including BioXcel Therapeutics Inc (BTAI) .
Click here to see the complete history of Krishnan Nandabalan’s form 4 insider trades.
Insider Ownership Summary of Krishnan Nandabalan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2023-04-06 | director & 10 percent owner |
Krishnan Nandabalan Latest Holdings Summary
Krishnan Nandabalan currently owns a total of 1 stock. Krishnan Nandabalan owns 8,546,750 shares of BioXcel Therapeutics Inc (BTAI) as of April 6, 2023, with a value of $16 Million.
Latest Holdings of Krishnan Nandabalan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2023-04-06 | 8,546,750 | 1.85 | 15,811,488 |
Holding Weightings of Krishnan Nandabalan
Krishnan Nandabalan Form 4 Trading Tracker
According to the SEC Form 4 filings, Krishnan Nandabalan has made a total of 4 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in BioXcel Therapeutics Inc is the sale of 60,000 shares on April 6, 2023, which brought Krishnan Nandabalan around $1 Million.
Insider Trading History of Krishnan Nandabalan
- 1
Krishnan Nandabalan Trading Performance
GuruFocus tracks the stock performance after each of Krishnan Nandabalan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Krishnan Nandabalan is 85.84%. GuruFocus also compares Krishnan Nandabalan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Krishnan Nandabalan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Krishnan Nandabalan's insider trading performs compared to the benchmark.
Performance of Krishnan Nandabalan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.7 | | | | | |
| Relative Return to S&P 500(%) | -7.49 | | | | | |
Krishnan Nandabalan Ownership Network
Krishnan Nandabalan Owned Company Details
What does BioXcel Therapeutics Inc do?
Who are the key executives at BioXcel Therapeutics Inc?
Krishnan Nandabalan is the director & 10 percent owner of BioXcel Therapeutics Inc. Other key executives at BioXcel Therapeutics Inc include CHIEF COMMERCIAL OFFICER Matthew T. Wiley , Chief Financial Officer Richard I Steinhart , and Chief Scientific Officer Frank Yocca .
BioXcel Therapeutics Inc (BTAI) Insider Trades Summary
Over the past 18 months, Krishnan Nandabalan made 2 insider transaction in BioXcel Therapeutics Inc (BTAI) with a net sale of 120,000. Other recent insider transactions involving BioXcel Therapeutics Inc (BTAI) include a net sale of 196,268 shares made by Vimal Mehta , a net sale of 52,052 shares made by Frank Yocca , and a net sale of 30,723 shares made by Vincent O'neill .
In summary, during the past 3 months, insiders sold 9,589 shares of BioXcel Therapeutics Inc (BTAI) in total and bought 0 shares, with a net sale of 9,589 shares. During the past 18 months, 411,951 shares of BioXcel Therapeutics Inc (BTAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 411,951 shares.
BioXcel Therapeutics Inc (BTAI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioXcel Therapeutics Inc Insider Transactions
Krishnan Nandabalan Mailing Address
Above is the net worth, insider trading, and ownership report for Krishnan Nandabalan. You might contact Krishnan Nandabalan via mailing address: 228 Village Pond Road, Guilford Ct 06437.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
